	Zinsaufwendungen Für Schuld		Datum
Acadia Pharmaceuticals	USD 0	4.12M	2024-09
Agios Pharmaceuticals	USD 1.39B	85.53M	2025-09
Alnylam Pharmaceuticals	USD 129.34M	84.94M	2025-12
Amarin	USD 3K	5K	2024-12
Amgen	USD 653M	32M	2025-12
Baxter International	USD 58M	14M	2025-09
Cara Therapeutics	43.75M	4.8M	2025-06
Cytokinetics	USD 30.33M	4.01M	2025-12
DBV Technologies	USD 461K	323.71K	2025-03
Eli Lilly	USD 114.7M	134.3M	2025-09
Esperion Therapeutics	USD 15.08M	1.36M	2024-09
Halozyme Therapeutics	USD 4.91M	615K	2025-12
Intrexon	USD 2K	5K	2024-06
Ionis Pharmaceuticals	USD 18M	0	2025-12
MannKind	USD 13.87M	6.54M	2025-12
Minerva Neurosciences	USD 2.31M	60K	2024-06
Nektar Therapeutics	USD 6.02M	420K	2024-09
Pfizer	USD 711M	59M	2025-12
Rigel Pharmaceuticals	USD 2.06M	31K	2024-09
United Therapeutics	USD 3.1M	100K	2025-12
Vanda Pharmaceuticals	601.14M	23.61M	2025-09

Halozyme Therapeutics Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.